FDA issues an alert against the use of certain Baxter Solution Sets with Duo-Vent Spikes because they were incorrectly assembled with inverted slide c...
Lexicon stops development of its diabetes drug Zynquista that received an FDA complete response letter.
FDA warns Albuquerque, NM-based Sombra Cosmetics about CGMP violations in the manufacturing of finished drugs.
FDA approves Mesoblasts Ryoncil to treat some graft-versus-host disease pediatric patients.
FDA publishes an International Council for Harmonization draft M15 guidance on model-informed drug development principles.
FDA publishes a guidance with recommendations for participating in the agencys Advanced Manufacturing Technologies Designation Program.
FDA publishes the International Council on Harmonization E11A Pediatric Extrapolation guidance.
FDA publishes Annex 2 of the International Council on Harmonization Good Clinical Practice guidance.